Asembia 2022

昨今の複雑な情勢におけるバリュー定義

バリューを実証しアクセスを最適化するには、各ステークホルダーのバリュー定義を理解し、定義とニーズが製品のライフサイクル全体ににどのように影響を及ぼすのかを理解しているパートナーが必要です。Syneos Health Value and Access can simplify that complex landscape with a team purpose-built to ensure that all aspects of value demonstration aren’t just interconnected—they’re orchestrated to be optimized.

Adapting to Your Shifting Needs

The future of a product in today’s healthcare marketplace is intertwined with the brand’s ability to successfully navigate market access barriers at launch and through loss of exclusivity. Syneos Health Value and Access approaches market access questions with decades of experience, cross-functional expertise and unparalleled stakeholder insight.

Featured Sessions

How Market Access Has Changed the Way We Approach Launch Strategies

May 4 | 10:30午前 PT

Jon Haas Senior Director Market Access Solutions	Adrian Garcia Executive Vice President GSW Managed Markets	Tony Lanzone Senior Managing Director Value, Access & HEOR

Integrated Engagement of IDNs

May 4 | 3pm PT

Chris Lisanti Managing Director コマーシャル・アドバイザリーグループ	Howard Brock Senior Managing Director Head of Customer and Digital Engagement

詳細に興味がおありですか？ Explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:

• About Syneos Health Value & Access
• Value & Access Brochure
• Oncology Value & Access Fact Sheet
• Optimizing Engagement with Integrated Health Systems and Organized Customers
• About Our Payer Communications & Access Marketing Solutions 
• How Competition Affects Market Access for Rare Disease Therapeutics
• Future-Forward Planning: What Drug and Device Manufacturers Need to Know About Preventive Drug Lists
• 2021 Update: Non-Personal Promotion: What Do Payers Want?
• The Other Path to Access: Strategies for Direct Employer Engagement
• The Syneos Health Podcast: Trade and Distribution in Pharma: It's Complicated
• The Syneos Health Podcast: Getting Access